Chemotherapy News and Research

Latest Chemotherapy News and Research

Feds move to rein in prior authorization, a system that harms and frustrates patients

When Paula Chestnut needed hip replacement surgery last year, a pre-operative X-ray found irregularities in her chest.

13 Mar 2023

Scientists identify the cause of leukemia in people with trisomy 21

People with a third copy of chromosome 21, known as trisomy 21, are at high risk of developing Acute Myeloid Leukaemia (AML), an aggressive form of blood cancer.

10 Mar 2023

Advanced imaging method shows promise to improve prostate cancer diagnosis

An advanced imaging method is showing promise as a way to improve the diagnosis of prostate cancer by giving clinicians a clearer view of suspected tumors during biopsy.

10 Mar 2023

Montana considers new wave of legislation to loosen vaccination rules

When Deb Horning's youngest daughter was 5, she got her measles, mumps, and rubella shot like many other kindergartners. But unlike many other moms, Horning had to stay away from her daughter for a week after the shot.

10 Mar 2023

Nirogacestat shows promising results in patients with desmoid tumors

When Dana Avellino, now 36, first noticed a lump near her groin in the summer of 2018, she thought it was related her recent cesarean section. Her younger daughter was only 2 months old at the time.

9 Mar 2023

Breakthrough drug works against all the main types of primary bone cancer

Researchers at the University of East Anglia have developed a new drug that works against all of the main types of primary bone cancer.

8 Mar 2023

Research shows the benefits of screening AML patients in remission for residual disease before bone marrow transplant

Researchers at the National Institutes of Health show the benefits of screening adult patients in remission from acute myeloid leukemia (AML) for residual disease before receiving a bone marrow transplant.

7 Mar 2023

Study finds two substances capable of inhibiting proliferation of glioblastoma cells

Glioblastoma is a malignant tumor of the central nervous system (brain or spinal cord) and one of the deadliest types of cancer.

7 Mar 2023

Denosumab may benefit postmenopausal patients with hormone receptor-negative breast tumors and RANK protein expression

The drug denosumab is currently used to treat osteoporosis and bone metastases. For more than a decade, its potential therapeutic benefit in the treatment of breast cancer has also been studied.

7 Mar 2023

Covid aid papered over Colorado hospital’s financial shortcomings

Less than two years after opening a state-of-the-art $26 million hospital in Leadville, Colorado, St. Vincent Health nearly ran out of money.

7 Mar 2023

CDC recommendations and clinical considerations for the treatment of severe Mpox

In a recent article published in the United States (U.S.) Centers for Disease Control and Prevention's (CDC) Morbidity and Mortality Weekly Report, a team of researchers discussed the medical countermeasures and clinical considerations for treating severe manifestations of Mpox.

6 Mar 2023

New research pinpoints key culprit behind brain cancer metastasis in children

New research pinpoints a key cause of metastasis from an aggressive form of brain cancer in children and provides a potential new therapy for treating these tumors in the future.

6 Mar 2023

Virtual or in person: Which kind of doctor’s visit is better, and when it matters

When the covid-19 pandemic swept the country in early 2020 and emptied doctors' offices nationwide, telemedicine was suddenly thrust into the spotlight. Patients and their physicians turned to virtual visits by video or phone rather than risk meeting face-to-face.

6 Mar 2023

Discovery about cell membrane 'blebs' could lead to new ways to fight melanoma

Cell membrane protrusions called blebs that typically signify the end of life for healthy cells do the opposite for melanoma cells, activating processes in these cells that help them to survive and spread, a UT Southwestern study suggests.

3 Mar 2023

Quiescent ovarian cancer cells secrete a protein to induce chemotherapy resistance in neighboring cells

Certain chemotherapy-resistant ovarian cancer cells protect neighboring cancer cells by sending signals that induce resistance, according to a new study from University of Pittsburgh and UPMC researchers that may help explain why ovarian cancer patients respond poorly to chemotherapy or relapse after treatment.

3 Mar 2023

Chemotherapy News and Research

Latest Chemotherapy News and Research

Feds move to rein in prior authorization, a system that harms and frustrates patients

Scientists identify the cause of leukemia in people with trisomy 21

Advanced imaging method shows promise to improve prostate cancer diagnosis

Montana considers new wave of legislation to loosen vaccination rules

Nirogacestat shows promising results in patients with desmoid tumors

Breakthrough drug works against all the main types of primary bone cancer

Research shows the benefits of screening AML patients in remission for residual disease before bone marrow transplant

Study finds two substances capable of inhibiting proliferation of glioblastoma cells

Denosumab may benefit postmenopausal patients with hormone receptor-negative breast tumors and RANK protein expression

Covid aid papered over Colorado hospital’s financial shortcomings

CDC recommendations and clinical considerations for the treatment of severe Mpox

New research pinpoints key culprit behind brain cancer metastasis in children

Virtual or in person: Which kind of doctor’s visit is better, and when it matters

Discovery about cell membrane 'blebs' could lead to new ways to fight melanoma

Quiescent ovarian cancer cells secrete a protein to induce chemotherapy resistance in neighboring cells

California’s massive Medicaid program works for some, but fails many others

What is the role of B cells in breast cancer pathology?

Chemotherapy affects the cellular landscape of tumor microenvironment in pancreatic cancer

Largest genomic study focuses on the prognosis of metastatic pheochromocytomas

Applying an evolutionary perspective to medicine can spark biomedical innovations

Cancer Research - Second Edition eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in